sofwave treatment loose skin thighs glp-1 Sofwave Improving Aesthetic Results for GLP-1

This targeted microbiome approach reflects growing research connecting gut health with metabolic balance and long-term wellness

In late 2024 tirzepatide (Zepbound) became the first GLP-1 and first medication to be approved for sleep apnea

Reduced systemic inflammation may lower the inflammatory tone in the brain

This means that is not well studied currently, there is no reliable information on the safety and side effects of microdosing GLP-1, and there are no guidelines on how microdosing should occur

By Route of Administration, Injectables Remain the Backbone Through 2035 Injectable formulations account for nearly 99% of obesity GLP-1 therapy use in 2025, reflecting their status as the established delivery route for both semaglutide and tirzepatide

Diem, Ducluzeau, Scheen)